Slide 1: Year-end report January — December 2013
GETINGE GROUP GETINGE GROUP Year-end report January — December 2013 January 28, 2014 Johan Malmaquist, CEO Ulf Grunander, CFO
Slide 2: Organic sales growth by region, Q4 and YTD 2013
2013 2013 Q4 YTD MS EC IC TOT MS EC IC TOT Europe 7.7 % 0.9 % 2.2 % 4.1 % 2.3 % -0.5% 1.9 % 1.3 % USA and Canada 1.7 % -0.8 % 3.7 % 1.4 % 4.1 % 3.0 % 5.7 % 4.2 % Rest of the world 16.9 % -7.9 % 14.9 % 12.9 % 9.9 % -1.2 % 3.0 % 6.9 % Total 9.4 % -1.2 % 6.2 % 5.9 % 5.8 % 0.5 % 3.4 % 4.0 % Q4 REPORT 20
Slide 3: Group financial results Q4 2013
2013 2012 2013 2012 Q4 Q4 Change % YTD YTD Change % Net sales, SEK M 7 757 7 816 -0,8% 25 287 24 248 4.3 % Gross margin 52.9 % 51.5 % 1.4 % 51.9 % 52.4 % -0.5 % Operating cost, SEK M -2 188 -2 241 -2.4 % -8 962 -8 470 5.8 % EBITA before restructuring 2 062 1 943 6.1 % 4 766 4 849 -1.7 % EBITA margin
Slide 4: Medical Systems financial results
2013 2012 2013 2012 Q4 Q4 Change % YTD YTD Change % 4 312 4 295 0.4 % 13 322 13 089 1.8 % Net sales, SEK M 58.1 % 58.2 % -0.1 % 58.5 % 58.6 % -0.1 % Gross margin % Operating cost, SEK M -1 266 -1 362 -7.0 % -5 356 -5 236 2.3 % EBITA before restructuring 1 353 1 263 7.1 % 2 894 2 945 -1.7 % EBITA mar
Slide 5: Medical Systems highlights
ms GETINGE GROUP = Public offer to acquire Pulsion Medical Systems - hemodynamic monitoring leader = Efficiency program within Critical Care division to save SEK 60 M per annum. = Medical Systems enhancing its quality management systems. = Integration of Atrium completed. = Restructuring activities
Slide 6: Extended Care financial results
2013 2012 2013 2012 Q4 Q4 Change % YTD YTD Change % 1 840 1 776 3.6 % 6 870 5 990 14.7 % Net sales, SEK M 51.1 % 48.7 % 2.4 % 49.0 % 51.0 % -2.0 % Gross margin % Operating cost, SEK M -520 -521 -0.2 % -2 202 -1 871 17.7 % EBITA before restructuring 452 373 21.2 % 1 296 1 274 1.7 % EBITA margin 24.6
Slide 7: Extended Care highlights
€ GETINGE GROUP Harald Stock — new Executive Vice President Extended Care as of January 1, 2014. Integration of TSS - greater cost synergies than originally anticipated, slight delay in synergy realization. Closing of manufacturing facilities in Sweden and Germany proceeding as planned. Maxi Transfe
Slide 8: Infection Control financial results
2013 2012 2013 2012 Q4 Q4 Change % YTD YTD Change % 1 606 1 745 -8.0 % 5 095 5 170 -1.5 % Net sales, SEK M 39.7 % 37.9 % 1.8 % 38.6 % 38.4 % 0.2 % Gross margin % -387 -358 8.1 % -1 405 -1 363 3.1 % Operating cost, SEK M 254 306 -17.0 % 575 631 -8.9 % EBITA before restructuring EBITA margin 15.8 % 17
Slide 9: Infection Control highlights
rol GETINGE GROUP = The efficiency-enhancement program to improve the business area’s profitability proceeding as planned. = New Generation of platform-based Steam Sterilizers, GSS67, was introduced in the quarter. * New patented user interface, Centric, was introduced.
Slide 10: Cash flow and net debt
2013 2012 2013 2012 Q4 Q4 YTD YTD Cash flow from operation, SEK million 1 410 1 457 3 544 3 687 Cash conversion, % 63.1 % 64.1 % Net Debt, SEK million 18 319 18 382 Equity, SEK million 16 610 15 200 Equity / assets ratio, % 37.4 % 35.4 % Net debt / equity ratio, multiple 1.10 1.21 Q4 REPORT 2013
Slide 11: Outlook 2014
GETINGE GROUP OUTLOOK 2014
Slide 12: Outlook 2014
GETINGE GROUP Organic revenue growth is expected to be comparable to 2013 levels at approximately 4 %. Restructuring costs are estimated to amount to approx. SEK 145 M for 2014. The strengthening of the Swedish krona will result in negative currency transaction effects of approx. SEK 250 M As a resu
Slide 13: Q&A
GETINGE GROUP Q&A
Slide 14: Forward looking information
GETINGE GROUP Forward looking information This document contains forward-looking information based on the current expectations of the Getinge Group’s management. Although management deems that the expectations presented by such forward-looking information are reasonable, no guarantee can be given th